New Zealand markets closed

Roche Holding AG (RHHBY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
49.35-0.17 (-0.33%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close49.51
Open49.84
BidN/A x N/A
AskN/A x N/A
Day's range49.08 - 49.94
52-week range39.80 - 51.05
Volume556,951
Avg. volume794,073
Market cap341.065B
Beta (5Y monthly)0.28
PE ratio (TTM)22.31
EPS (TTM)2.21
Earnings dateN/A
Forward dividend & yield1.22 (2.47%)
Ex-dividend date18 Mar 2021
1y target est56.44
  • GlobeNewswire

    Changes in the Board of Directors

    Professor Dr. Jemilah Mahmood portrait photo Portrait photo Basel, 3 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that at its December meeting the Board of Directors of Roche Holding Ltd has approved first proposals to the Annual General Meeting (AGM) scheduled for 15 March 2022. Mr Paul Bulcke, who has been serving on the Board of Directors since 2011, has decided not to stand for re-election at the AGM in 2022, following almost eleven years of tenure. The Board of Directo

  • Zacks

    Novartis (NVS) Highlights Growth Profile at its R&D Day

    Novartis (NVS) throws light on its pipeline progress, key areas of focus and long-term targets at its R&D day. Here, we discuss key highlights from the same.

  • GlobeNewswire

    Roche has rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant

    Roche subsidiary TIB Molbiol rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant, as they continue to offer new and accurate detection solutionsThree new testing kits are among the first to specify the mutations of the recently discovered Omicron variant, and can help manage the evolving COVID-19 pandemicUse of these new tests assess the spread of circulating variants and can help monitor the potential impact of therapeutics, vaccines, and pu